Clearmind Medicine Inc. Cash And Cash Equivalents
Clearmind Medicine Inc. (CMND) had Cash And Cash Equivalents of $9.26 million as of 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-12
- 2023-01-31: Cash And Cash Equivalents 4.50M CAD.
- 2022-10-31: Cash And Cash Equivalents 175.77K CAD.
- 2022-01-31: Cash And Cash Equivalents 2.81M CAD.
- 2021-10-31: Cash And Cash Equivalents 4.60M CAD.
CAD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2023-01-31 | 4.50M CAD 6-K · filed 2023-03-17 |
| 2022-10-31 | 175.77K CAD 6-K · filed 2023-03-17 |
| 2022-01-31 | 2.81M CAD 6-K · filed 2023-03-17 |
| 2021-10-31 | 4.60M CAD 6-K · filed 2023-03-17 |
| 2020-10-31 | 329.84K CAD 20-F · filed 2023-02-06 |
| 2019-10-31 | 688.00 CAD 20-F · filed 2023-02-06 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2026-01-31 | $9.26M 6-K · filed 2026-03-12 |
| 2025-10-31 | $3.92M 6-K · filed 2026-03-12 |
| 2025-07-31 | $3.50M 6-K · filed 2025-09-11 |
| 2025-04-30 | $4.47M 6-K · filed 2025-06-12 |
| 2025-01-31 | $5.78M 6-K · filed 2026-03-12 |
| 2024-10-31 | $6.57M 6-K · filed 2026-03-12 |
| 2024-07-31 | $7.68M 6-K · filed 2025-09-11 |
| 2024-04-30 | $8.31M 6-K · filed 2025-06-12 |
| 2024-01-31 | $9.29M 6-K · filed 2025-03-13 |
| 2023-10-31 | $5.43M 20-F · filed 2026-01-20 |
| 2023-07-31 | $3.85M 6-K · filed 2024-09-16 |
| 2023-04-30 | $5.25M 6-K · filed 2024-06-13 |
| 2023-01-31 | $3.37M 6-K · filed 2024-03-19 |
| 2022-10-31 | $128.78K 20-F · filed 2026-01-20 |
| 2021-10-31 | $3.37M 20-F · filed 2025-01-22 |
| 2020-10-31 | $241.66K 20-F/A · filed 2024-03-18 |